| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 49 | 2025 | 916 | 5.330 |
Why?
|
| Ovarian Neoplasms | 9 | 2019 | 462 | 1.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 24 | 2020 | 2062 | 1.330 |
Why?
|
| Gene Expression Profiling | 30 | 2022 | 1883 | 1.270 |
Why?
|
| Sequence Analysis, RNA | 10 | 2020 | 409 | 1.100 |
Why?
|
| Embryonic Stem Cells | 5 | 2013 | 167 | 1.090 |
Why?
|
| Cell Movement | 6 | 2024 | 891 | 1.070 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2020 | 491 | 0.950 |
Why?
|
| Tumor Suppressor Protein p53 | 11 | 2020 | 770 | 0.920 |
Why?
|
| Cell Differentiation | 18 | 2024 | 1965 | 0.830 |
Why?
|
| RNA, Messenger | 15 | 2021 | 2680 | 0.810 |
Why?
|
| Computational Biology | 7 | 2012 | 876 | 0.800 |
Why?
|
| Breast Neoplasms | 9 | 2025 | 2681 | 0.800 |
Why?
|
| RNA, Long Noncoding | 7 | 2021 | 240 | 0.790 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 138 | 0.760 |
Why?
|
| Cell Line, Tumor | 26 | 2025 | 3691 | 0.750 |
Why?
|
| Gene Expression Regulation | 15 | 2024 | 2442 | 0.750 |
Why?
|
| Transcription Factors | 10 | 2020 | 2491 | 0.740 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 188 | 0.730 |
Why?
|
| Gene Regulatory Networks | 10 | 2018 | 387 | 0.710 |
Why?
|
| Cisplatin | 2 | 2019 | 282 | 0.700 |
Why?
|
| Animals | 78 | 2025 | 34854 | 0.700 |
Why?
|
| Phosphoproteins | 8 | 2020 | 443 | 0.670 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2024 | 1018 | 0.640 |
Why?
|
| Osteosarcoma | 3 | 2019 | 263 | 0.640 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2025 | 816 | 0.640 |
Why?
|
| Ribonuclease III | 6 | 2014 | 99 | 0.630 |
Why?
|
| Neoplasms | 9 | 2025 | 2961 | 0.630 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2018 | 209 | 0.620 |
Why?
|
| Mice | 54 | 2025 | 18509 | 0.600 |
Why?
|
| Signal Transduction | 18 | 2025 | 4720 | 0.570 |
Why?
|
| Transcriptional Activation | 2 | 2019 | 430 | 0.560 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2014 | 147 | 0.560 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2020 | 623 | 0.530 |
Why?
|
| DNA, Complementary | 8 | 2010 | 454 | 0.520 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 44 | 0.500 |
Why?
|
| Sequence Analysis, DNA | 11 | 2015 | 1803 | 0.500 |
Why?
|
| Neuroblastoma | 4 | 2016 | 550 | 0.480 |
Why?
|
| Hepatoblastoma | 3 | 2022 | 183 | 0.470 |
Why?
|
| Tretinoin | 2 | 2013 | 102 | 0.470 |
Why?
|
| Gold | 3 | 2023 | 56 | 0.460 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2015 | 106 | 0.450 |
Why?
|
| Trans-Activators | 7 | 2020 | 712 | 0.450 |
Why?
|
| Finches | 2 | 2011 | 6 | 0.440 |
Why?
|
| Mutation, Missense | 1 | 2019 | 937 | 0.440 |
Why?
|
| Muscle Development | 3 | 2024 | 73 | 0.430 |
Why?
|
| Nuclear Proteins | 6 | 2020 | 1285 | 0.420 |
Why?
|
| Myoblasts | 2 | 2024 | 37 | 0.420 |
Why?
|
| Liver Neoplasms | 4 | 2024 | 1381 | 0.420 |
Why?
|
| Humans | 91 | 2025 | 132247 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2025 | 768 | 0.410 |
Why?
|
| Multiple Myeloma | 2 | 2015 | 202 | 0.390 |
Why?
|
| Base Sequence | 20 | 2020 | 2900 | 0.390 |
Why?
|
| Cysteamine | 1 | 2012 | 15 | 0.390 |
Why?
|
| Genitalia, Female | 3 | 2010 | 46 | 0.390 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2017 | 946 | 0.380 |
Why?
|
| Vocalization, Animal | 2 | 2011 | 24 | 0.370 |
Why?
|
| Transcription, Genetic | 11 | 2016 | 1423 | 0.370 |
Why?
|
| Neoplasm Invasiveness | 5 | 2025 | 665 | 0.370 |
Why?
|
| Transcriptome | 8 | 2024 | 1125 | 0.360 |
Why?
|
| Cell Proliferation | 15 | 2024 | 2511 | 0.360 |
Why?
|
| Down-Regulation | 6 | 2019 | 679 | 0.350 |
Why?
|
| Prosencephalon | 1 | 2011 | 43 | 0.350 |
Why?
|
| Auditory Cortex | 1 | 2011 | 28 | 0.350 |
Why?
|
| Ovary | 3 | 2011 | 371 | 0.350 |
Why?
|
| Wnt Proteins | 4 | 2016 | 224 | 0.350 |
Why?
|
| Homeodomain Proteins | 6 | 2020 | 569 | 0.340 |
Why?
|
| Biomarkers, Tumor | 7 | 2017 | 1683 | 0.340 |
Why?
|
| Skin Neoplasms | 5 | 2025 | 897 | 0.330 |
Why?
|
| Carcinogenesis | 4 | 2025 | 359 | 0.330 |
Why?
|
| Neoplastic Stem Cells | 4 | 2016 | 348 | 0.330 |
Why?
|
| Oncogene Proteins | 1 | 2011 | 144 | 0.330 |
Why?
|
| Software | 3 | 2012 | 732 | 0.330 |
Why?
|
| Breast | 3 | 2023 | 217 | 0.320 |
Why?
|
| Chromatin | 1 | 2013 | 520 | 0.320 |
Why?
|
| Mice, Knockout | 10 | 2024 | 3868 | 0.320 |
Why?
|
| Gene Expression | 3 | 2011 | 1563 | 0.310 |
Why?
|
| Nanoparticles | 1 | 2012 | 288 | 0.310 |
Why?
|
| Mice, Nude | 5 | 2025 | 755 | 0.310 |
Why?
|
| Female | 48 | 2025 | 70787 | 0.310 |
Why?
|
| Myocytes, Cardiac | 4 | 2024 | 652 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 8 | 2017 | 1284 | 0.300 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 75 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 11 | 2017 | 1045 | 0.290 |
Why?
|
| Stem Cells | 4 | 2019 | 733 | 0.290 |
Why?
|
| Nucleic Acid Conformation | 5 | 2021 | 182 | 0.290 |
Why?
|
| Glucocorticoids | 1 | 2011 | 387 | 0.290 |
Why?
|
| RNA Editing | 1 | 2008 | 36 | 0.290 |
Why?
|
| Membrane Proteins | 6 | 2024 | 1597 | 0.280 |
Why?
|
| Endoribonucleases | 2 | 2024 | 85 | 0.280 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2016 | 380 | 0.270 |
Why?
|
| Protein Isoforms | 5 | 2024 | 422 | 0.270 |
Why?
|
| Laminin | 2 | 2025 | 72 | 0.270 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 608 | 0.260 |
Why?
|
| Cells, Cultured | 10 | 2021 | 3046 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2020 | 998 | 0.250 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 1037 | 0.250 |
Why?
|
| Bacterial Proteins | 3 | 2021 | 930 | 0.240 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 217 | 0.240 |
Why?
|
| Models, Biological | 4 | 2019 | 1445 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 8 | 2017 | 1045 | 0.240 |
Why?
|
| Wnt Signaling Pathway | 4 | 2023 | 205 | 0.240 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2025 | 152 | 0.240 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2025 | 40 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 4758 | 0.230 |
Why?
|
| Lignin | 1 | 2025 | 18 | 0.230 |
Why?
|
| Free Radical Scavengers | 1 | 2025 | 58 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2019 | 635 | 0.230 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 101 | 0.220 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2025 | 304 | 0.220 |
Why?
|
| Obesity | 4 | 2021 | 2398 | 0.220 |
Why?
|
| Integrin beta1 | 1 | 2024 | 56 | 0.220 |
Why?
|
| Cell Fusion | 1 | 2024 | 35 | 0.220 |
Why?
|
| Molecular Sequence Data | 14 | 2015 | 3771 | 0.220 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2024 | 27 | 0.220 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2025 | 133 | 0.220 |
Why?
|
| Fibronectins | 1 | 2024 | 103 | 0.220 |
Why?
|
| Transfection | 4 | 2023 | 996 | 0.220 |
Why?
|
| Keratinocytes | 2 | 2014 | 62 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2025 | 145 | 0.210 |
Why?
|
| Genomics | 5 | 2018 | 1652 | 0.210 |
Why?
|
| DNA, Concatenated | 1 | 2003 | 5 | 0.210 |
Why?
|
| TWEAK Receptor | 1 | 2023 | 3 | 0.210 |
Why?
|
| Genes, MHC Class I | 1 | 2023 | 12 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 1 | 2025 | 210 | 0.210 |
Why?
|
| Precancerous Conditions | 2 | 2017 | 280 | 0.210 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2014 | 57 | 0.210 |
Why?
|
| Exosomes | 1 | 2024 | 57 | 0.210 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 237 | 0.200 |
Why?
|
| Metal Nanoparticles | 1 | 2023 | 56 | 0.200 |
Why?
|
| DNA Mutational Analysis | 5 | 2016 | 826 | 0.200 |
Why?
|
| Chronic Pain | 1 | 2025 | 148 | 0.200 |
Why?
|
| Cloning, Molecular | 6 | 2009 | 811 | 0.200 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 689 | 0.200 |
Why?
|
| Drosophila melanogaster | 5 | 2014 | 843 | 0.200 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 118 | 0.200 |
Why?
|
| Oncogenes | 3 | 2019 | 177 | 0.200 |
Why?
|
| Receptor, ErbB-2 | 2 | 2025 | 549 | 0.200 |
Why?
|
| Epidermis | 3 | 2024 | 64 | 0.200 |
Why?
|
| Cell Communication | 1 | 2023 | 186 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2025 | 444 | 0.190 |
Why?
|
| Chickens | 3 | 2012 | 303 | 0.190 |
Why?
|
| Inflammation | 5 | 2025 | 1522 | 0.190 |
Why?
|
| Lymphoma | 2 | 2016 | 331 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 516 | 0.190 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 286 | 0.190 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 76 | 0.180 |
Why?
|
| Cell Line | 6 | 2018 | 2724 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2024 | 283 | 0.180 |
Why?
|
| RNA Nucleotidyltransferases | 2 | 2014 | 31 | 0.180 |
Why?
|
| DNA Copy Number Variations | 4 | 2018 | 1034 | 0.180 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 10 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2025 | 394 | 0.180 |
Why?
|
| X Chromosome | 3 | 2014 | 340 | 0.180 |
Why?
|
| Interferon-gamma | 1 | 2024 | 539 | 0.180 |
Why?
|
| Phenylketonurias | 1 | 2021 | 14 | 0.180 |
Why?
|
| Oxygen | 1 | 2025 | 569 | 0.180 |
Why?
|
| Curcumin | 1 | 2021 | 43 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 4 | 2019 | 403 | 0.180 |
Why?
|
| Wound Healing | 1 | 2025 | 475 | 0.180 |
Why?
|
| RNA Stability | 2 | 2014 | 83 | 0.170 |
Why?
|
| Simplexvirus | 1 | 2021 | 100 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 124 | 0.170 |
Why?
|
| Influenza in Birds | 2 | 2012 | 28 | 0.170 |
Why?
|
| Mutation | 7 | 2019 | 6250 | 0.170 |
Why?
|
| Algorithms | 6 | 2013 | 1725 | 0.170 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 111 | 0.170 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 255 | 0.170 |
Why?
|
| Oncolytic Viruses | 1 | 2021 | 76 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 471 | 0.170 |
Why?
|
| Antibodies, Bispecific | 1 | 2021 | 52 | 0.170 |
Why?
|
| ErbB Receptors | 2 | 2009 | 296 | 0.170 |
Why?
|
| Neural Plate | 1 | 2020 | 13 | 0.160 |
Why?
|
| Oncolytic Virotherapy | 1 | 2021 | 89 | 0.160 |
Why?
|
| Gastrula | 2 | 2020 | 22 | 0.160 |
Why?
|
| Micrococcus luteus | 1 | 2019 | 2 | 0.160 |
Why?
|
| Databases, Nucleic Acid | 2 | 2012 | 73 | 0.160 |
Why?
|
| Lymphocytes | 3 | 2018 | 364 | 0.160 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 1018 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2019 | 613 | 0.160 |
Why?
|
| Heart Ventricles | 1 | 2024 | 785 | 0.160 |
Why?
|
| Adipocytes | 3 | 2020 | 182 | 0.160 |
Why?
|
| Biological Clocks | 1 | 2019 | 29 | 0.160 |
Why?
|
| Embryo, Mammalian | 5 | 2017 | 441 | 0.160 |
Why?
|
| Prognosis | 8 | 2024 | 5016 | 0.160 |
Why?
|
| Body Patterning | 1 | 2020 | 130 | 0.160 |
Why?
|
| Mouse Embryonic Stem Cells | 2 | 2016 | 34 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2021 | 173 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 126 | 0.160 |
Why?
|
| Killer Cells, Natural | 2 | 2020 | 351 | 0.160 |
Why?
|
| Angiotensin II | 1 | 2020 | 163 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 92 | 0.150 |
Why?
|
| Up-Regulation | 3 | 2019 | 881 | 0.150 |
Why?
|
| Male | 28 | 2025 | 65014 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2019 | 117 | 0.150 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2019 | 148 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2020 | 240 | 0.150 |
Why?
|
| POU Domain Factors | 1 | 2018 | 8 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2019 | 64 | 0.150 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2018 | 34 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2019 | 76 | 0.150 |
Why?
|
| Cell Cycle Proteins | 4 | 2016 | 685 | 0.150 |
Why?
|
| Heat-Shock Proteins | 1 | 2019 | 183 | 0.150 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 262 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2017 | 236 | 0.150 |
Why?
|
| Palatine Tonsil | 1 | 2018 | 36 | 0.150 |
Why?
|
| CpG Islands | 4 | 2013 | 343 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 4 | 2011 | 1555 | 0.150 |
Why?
|
| Radiation Exposure | 1 | 2019 | 50 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 333 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2018 | 96 | 0.140 |
Why?
|
| Multigene Family | 4 | 2013 | 305 | 0.140 |
Why?
|
| Liposomes | 1 | 2019 | 203 | 0.140 |
Why?
|
| Telomerase | 2 | 2016 | 168 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 570 | 0.140 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1829 | 0.140 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 210 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 1285 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 224 | 0.140 |
Why?
|
| Gene Library | 3 | 2009 | 213 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 81 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 45 | 0.140 |
Why?
|
| Binding Sites | 3 | 2019 | 1256 | 0.140 |
Why?
|
| Polylysine | 1 | 2017 | 11 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2019 | 260 | 0.140 |
Why?
|
| Repressor Proteins | 3 | 2017 | 813 | 0.140 |
Why?
|
| DNA-Binding Proteins | 5 | 2014 | 1997 | 0.140 |
Why?
|
| Methylation | 2 | 2017 | 208 | 0.130 |
Why?
|
| Cell Lineage | 5 | 2018 | 358 | 0.130 |
Why?
|
| Immunohistochemistry | 4 | 2021 | 1718 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 198 | 0.130 |
Why?
|
| Minisatellite Repeats | 1 | 1997 | 45 | 0.130 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 74 | 0.130 |
Why?
|
| Tissue Distribution | 3 | 2010 | 380 | 0.130 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1997 | 64 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 413 | 0.130 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 49 | 0.130 |
Why?
|
| Genetic Techniques | 2 | 2010 | 104 | 0.130 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 755 | 0.130 |
Why?
|
| Keratosis, Actinic | 1 | 2016 | 14 | 0.130 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2014 | 59 | 0.130 |
Why?
|
| Histones | 3 | 2017 | 535 | 0.130 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2017 | 69 | 0.120 |
Why?
|
| beta Catenin | 3 | 2019 | 227 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2016 | 89 | 0.120 |
Why?
|
| Cell Survival | 3 | 2015 | 868 | 0.120 |
Why?
|
| DNA Methylation | 4 | 2018 | 1122 | 0.120 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 63 | 0.120 |
Why?
|
| Mammary Glands, Animal | 3 | 2020 | 455 | 0.120 |
Why?
|
| DNA Replication | 2 | 1995 | 353 | 0.120 |
Why?
|
| Heart | 2 | 2017 | 689 | 0.120 |
Why?
|
| Smad1 Protein | 1 | 2015 | 23 | 0.120 |
Why?
|
| Genes | 5 | 2011 | 313 | 0.120 |
Why?
|
| Gene Silencing | 2 | 2015 | 239 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 86 | 0.120 |
Why?
|
| Xenopus | 1 | 2015 | 103 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 347 | 0.120 |
Why?
|
| Xenopus Proteins | 1 | 2015 | 60 | 0.120 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 4690 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 256 | 0.120 |
Why?
|
| Host Cell Factor C1 | 2 | 2017 | 10 | 0.120 |
Why?
|
| Annexin A1 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2015 | 8 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2014 | 357 | 0.120 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 630 | 0.120 |
Why?
|
| Genome | 3 | 2010 | 504 | 0.120 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1995 | 17 | 0.120 |
Why?
|
| Genome-Wide Association Study | 4 | 2024 | 1831 | 0.120 |
Why?
|
| Estradiol | 2 | 2015 | 488 | 0.120 |
Why?
|
| Drosophila | 3 | 2014 | 824 | 0.110 |
Why?
|
| Protein Binding | 4 | 2021 | 1734 | 0.110 |
Why?
|
| Meiosis | 3 | 2010 | 116 | 0.110 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2014 | 13 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2015 | 446 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 11 | 1 | 2014 | 2 | 0.110 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2013 | 66 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 207 | 0.110 |
Why?
|
| Sezary Syndrome | 1 | 2014 | 14 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1994 | 79 | 0.110 |
Why?
|
| Myocardium | 1 | 2019 | 907 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 249 | 0.110 |
Why?
|
| Glucose Dehydrogenases | 1 | 1994 | 1 | 0.110 |
Why?
|
| Prader-Willi Syndrome | 1 | 1995 | 70 | 0.110 |
Why?
|
| Genomic Imprinting | 1 | 1995 | 130 | 0.110 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 689 | 0.110 |
Why?
|
| Apoptosis | 6 | 2017 | 1901 | 0.110 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 26 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2021 | 1612 | 0.110 |
Why?
|
| CDX2 Transcription Factor | 1 | 2013 | 10 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2014 | 615 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 810 | 0.100 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2013 | 29 | 0.100 |
Why?
|
| Proteins | 3 | 2014 | 1038 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 274 | 0.100 |
Why?
|
| Adenine | 1 | 2014 | 119 | 0.100 |
Why?
|
| Conserved Sequence | 3 | 2013 | 296 | 0.100 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2013 | 10 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 174 | 0.100 |
Why?
|
| Osteocytes | 1 | 2013 | 14 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 3018 | 0.100 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2013 | 67 | 0.100 |
Why?
|
| Estrogens | 1 | 2015 | 436 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1128 | 0.100 |
Why?
|
| Lung | 2 | 2012 | 1556 | 0.100 |
Why?
|
| Blotting, Northern | 2 | 2008 | 252 | 0.100 |
Why?
|
| Retroelements | 2 | 2010 | 40 | 0.100 |
Why?
|
| Microarray Analysis | 2 | 2012 | 236 | 0.100 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 9 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 94 | 0.090 |
Why?
|
| 3' Untranslated Regions | 4 | 2015 | 166 | 0.090 |
Why?
|
| RNA, Plant | 1 | 2012 | 8 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 243 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 1541 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 439 | 0.090 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 156 | 0.090 |
Why?
|
| Epithelial Cells | 3 | 2011 | 906 | 0.090 |
Why?
|
| Disease Progression | 4 | 2020 | 2233 | 0.090 |
Why?
|
| HEK293 Cells | 4 | 2019 | 799 | 0.090 |
Why?
|
| Homeobox Protein Nkx-2.5 | 2 | 2024 | 18 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 112 | 0.090 |
Why?
|
| Lactation | 1 | 2013 | 198 | 0.090 |
Why?
|
| Morphogenesis | 3 | 2024 | 203 | 0.090 |
Why?
|
| Expressed Sequence Tags | 3 | 2006 | 81 | 0.090 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 85 | 0.090 |
Why?
|
| Glucuronidase | 1 | 2011 | 30 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2018 | 893 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2011 | 302 | 0.090 |
Why?
|
| Testis | 2 | 2010 | 423 | 0.080 |
Why?
|
| Evolution, Molecular | 4 | 2010 | 700 | 0.080 |
Why?
|
| Spermatozoa | 2 | 2009 | 243 | 0.080 |
Why?
|
| Leukemia | 1 | 2013 | 372 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 272 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 984 | 0.080 |
Why?
|
| Drosophila Proteins | 3 | 2014 | 770 | 0.080 |
Why?
|
| Adipose Tissue, White | 2 | 2021 | 94 | 0.080 |
Why?
|
| Databases, Genetic | 3 | 2018 | 502 | 0.080 |
Why?
|
| Mice, Obese | 2 | 2021 | 76 | 0.080 |
Why?
|
| Sense Organs | 1 | 2010 | 18 | 0.080 |
Why?
|
| Carcinoma | 1 | 2013 | 300 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 2005 | 702 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 94 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 451 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2012 | 323 | 0.080 |
Why?
|
| Poultry Diseases | 1 | 2009 | 7 | 0.080 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2010 | 26 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2016 | 604 | 0.080 |
Why?
|
| Milk, Human | 1 | 2013 | 308 | 0.080 |
Why?
|
| Genetic Testing | 1 | 1997 | 1099 | 0.080 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2009 | 62 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2011 | 360 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 3 | 2020 | 309 | 0.080 |
Why?
|
| Lipids | 1 | 2013 | 561 | 0.080 |
Why?
|
| Transcription Factor HES-1 | 1 | 2009 | 18 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2009 | 27 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2009 | 39 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2016 | 384 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2014 | 261 | 0.070 |
Why?
|
| Internet | 1 | 2012 | 406 | 0.070 |
Why?
|
| Genes, Reporter | 3 | 2016 | 366 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2010 | 771 | 0.070 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 682 | 0.070 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2008 | 6 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 1062 | 0.070 |
Why?
|
| Regeneration | 2 | 2024 | 225 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 398 | 0.070 |
Why?
|
| RNA, Small Untranslated | 1 | 2008 | 21 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 107 | 0.070 |
Why?
|
| Brain | 2 | 2018 | 3194 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2010 | 291 | 0.070 |
Why?
|
| Cell Cycle | 3 | 2017 | 607 | 0.070 |
Why?
|
| Endometriosis | 1 | 2011 | 175 | 0.070 |
Why?
|
| Mammals | 1 | 2009 | 271 | 0.070 |
Why?
|
| Uterus | 1 | 2012 | 548 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2008 | 142 | 0.070 |
Why?
|
| Liver | 3 | 2024 | 1797 | 0.070 |
Why?
|
| Trachea | 1 | 2009 | 210 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2020 | 198 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2020 | 145 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 333 | 0.070 |
Why?
|
| Infertility | 1 | 2008 | 81 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2005 | 815 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 294 | 0.070 |
Why?
|
| Survival Rate | 3 | 2017 | 2196 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1354 | 0.070 |
Why?
|
| Open Reading Frames | 2 | 2004 | 218 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 579 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 551 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1304 | 0.060 |
Why?
|
| Proteomics | 2 | 2021 | 596 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2009 | 296 | 0.060 |
Why?
|
| Mesoderm | 2 | 2016 | 107 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2011 | 1080 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 502 | 0.060 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2018 | 241 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 94 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2006 | 94 | 0.060 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2025 | 12 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2005 | 66 | 0.060 |
Why?
|
| DNA | 5 | 2017 | 1479 | 0.060 |
Why?
|
| Embryonic Development | 2 | 2017 | 215 | 0.060 |
Why?
|
| Trialkyltin Compounds | 1 | 2024 | 7 | 0.060 |
Why?
|
| Interferon Type I | 1 | 2025 | 114 | 0.060 |
Why?
|
| Genomic Library | 1 | 2004 | 40 | 0.060 |
Why?
|
| Animals, Genetically Modified | 3 | 2014 | 341 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 99 | 0.060 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 217 | 0.060 |
Why?
|
| Cell Shape | 1 | 2024 | 69 | 0.060 |
Why?
|
| Biotechnology | 1 | 2004 | 59 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2009 | 749 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2016 | 80 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2016 | 316 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2005 | 158 | 0.050 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2024 | 38 | 0.050 |
Why?
|
| Endocrine Disruptors | 1 | 2024 | 53 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2005 | 247 | 0.050 |
Why?
|
| Cytosine | 2 | 2014 | 58 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2025 | 312 | 0.050 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 40 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1996 | 372 | 0.050 |
Why?
|
| Epigenomics | 1 | 2024 | 191 | 0.050 |
Why?
|
| Phenotype | 5 | 2015 | 4540 | 0.050 |
Why?
|
| Nucleotides | 2 | 2015 | 89 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2025 | 435 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 2451 | 0.050 |
Why?
|
| Argonaute Proteins | 2 | 2015 | 31 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2024 | 275 | 0.050 |
Why?
|
| Asthma | 1 | 2010 | 773 | 0.050 |
Why?
|
| Genetic Therapy | 2 | 2021 | 720 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2023 | 348 | 0.050 |
Why?
|
| Cell Growth Processes | 2 | 2013 | 65 | 0.050 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 146 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 11 | 0.050 |
Why?
|
| Time Factors | 2 | 2010 | 6451 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 3358 | 0.040 |
Why?
|
| Dystrophin | 1 | 2021 | 41 | 0.040 |
Why?
|
| Zebrafish | 2 | 2020 | 421 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2024 | 404 | 0.040 |
Why?
|
| Biomarkers | 2 | 2021 | 3404 | 0.040 |
Why?
|
| RNA Interference | 2 | 2014 | 515 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 1410 | 0.040 |
Why?
|
| Neurons | 2 | 2025 | 2015 | 0.040 |
Why?
|
| Porins | 1 | 2021 | 41 | 0.040 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2014 | 59 | 0.040 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 66 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 424 | 0.040 |
Why?
|
| Ischemia | 1 | 2024 | 371 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 526 | 0.040 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2000 | 2 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 140 | 0.040 |
Why?
|
| Diencephalon | 1 | 2020 | 10 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 543 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2020 | 58 | 0.040 |
Why?
|
| Receptors, KIR | 1 | 2020 | 10 | 0.040 |
Why?
|
| Ectoderm | 1 | 2020 | 31 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2020 | 39 | 0.040 |
Why?
|
| Gastrulation | 1 | 2020 | 22 | 0.040 |
Why?
|
| Glyoxylates | 1 | 2019 | 4 | 0.040 |
Why?
|
| Influenza A virus | 2 | 2012 | 152 | 0.040 |
Why?
|
| Rhombencephalon | 1 | 2020 | 48 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 293 | 0.040 |
Why?
|
| Aurora Kinase A | 1 | 2020 | 37 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2021 | 239 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2017 | 1365 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 2669 | 0.040 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2019 | 26 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 46 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2018 | 412 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 213 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 65 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 110 | 0.040 |
Why?
|
| Connexins | 1 | 2019 | 64 | 0.040 |
Why?
|
| Anilides | 1 | 2019 | 58 | 0.040 |
Why?
|
| Nervous System | 1 | 2020 | 127 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2025 | 565 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2000 | 201 | 0.040 |
Why?
|
| Gamma Rays | 1 | 2019 | 42 | 0.040 |
Why?
|
| Genes, Dominant | 2 | 1997 | 251 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2019 | 56 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2018 | 12 | 0.040 |
Why?
|
| Quartz Crystal Microbalance Techniques | 1 | 2018 | 1 | 0.040 |
Why?
|
| Wettability | 1 | 2018 | 2 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2006 | 526 | 0.040 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2018 | 7 | 0.040 |
Why?
|
| Sulfur | 1 | 2018 | 13 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2020 | 129 | 0.040 |
Why?
|
| Adsorption | 1 | 2018 | 36 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2020 | 165 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 231 | 0.040 |
Why?
|
| CD56 Antigen | 1 | 2018 | 29 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 159 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 172 | 0.040 |
Why?
|
| Quinolines | 1 | 2019 | 121 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2018 | 64 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 109 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2021 | 510 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 286 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2019 | 343 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2000 | 310 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2018 | 87 | 0.040 |
Why?
|
| Melanoma | 1 | 2025 | 954 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 1096 | 0.030 |
Why?
|
| Pyridines | 1 | 2019 | 249 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2019 | 431 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2017 | 33 | 0.030 |
Why?
|
| Diet, Western | 1 | 2017 | 18 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 18 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 70 | 0.030 |
Why?
|
| Adenoma | 1 | 2019 | 146 | 0.030 |
Why?
|
| Bradycardia | 1 | 2017 | 60 | 0.030 |
Why?
|
| Disease Management | 1 | 2021 | 565 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2017 | 2 | 0.030 |
Why?
|
| Child | 4 | 2016 | 25783 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 149 | 0.030 |
Why?
|
| Surface Properties | 1 | 2017 | 93 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2009 | 135 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2016 | 30 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 13 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2013 | 246 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2009 | 14736 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 38 | 0.030 |
Why?
|
| Luciferases | 2 | 2011 | 129 | 0.030 |
Why?
|
| CELF1 Protein | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 234 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 327 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2016 | 18 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2016 | 196 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 87 | 0.030 |
Why?
|
| Synteny | 2 | 2006 | 78 | 0.030 |
Why?
|
| DNA, Neoplasm | 2 | 2010 | 295 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 686 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 1997 | 195 | 0.030 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2015 | 12 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 81 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 125 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2021 | 1050 | 0.030 |
Why?
|
| bcl-X Protein | 1 | 2015 | 32 | 0.030 |
Why?
|
| Adult | 4 | 2025 | 31614 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 165 | 0.030 |
Why?
|
| Pan troglodytes | 2 | 2006 | 77 | 0.030 |
Why?
|
| Myelin Proteins | 1 | 1996 | 79 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 112 | 0.030 |
Why?
|
| Contig Mapping | 2 | 2006 | 53 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 251 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2009 | 8548 | 0.030 |
Why?
|
| Trisomy | 1 | 1996 | 112 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2018 | 413 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 651 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 125 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 159 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 196 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 175 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 2011 | 161 | 0.030 |
Why?
|
| Gelsolin | 1 | 1995 | 13 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 243 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 2014 | 15 | 0.030 |
Why?
|
| Euchromatin | 1 | 2014 | 13 | 0.030 |
Why?
|
| Tumor Protein p73 | 1 | 2014 | 27 | 0.030 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 135 | 0.030 |
Why?
|
| Receptors, Calcitonin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 559 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2014 | 36 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 803 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 608 | 0.030 |
Why?
|
| Base Pairing | 1 | 2014 | 42 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 77 | 0.030 |
Why?
|
| Protein Kinase C beta | 1 | 2014 | 20 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1161 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2014 | 100 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 742 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 83 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1994 | 309 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 62 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6568 | 0.030 |
Why?
|
| Glucose 1-Dehydrogenase | 1 | 1994 | 1 | 0.030 |
Why?
|
| Exoribonucleases | 1 | 2014 | 23 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1125 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1995 | 148 | 0.030 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1996 | 239 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 130 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2015 | 273 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1994 | 139 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 260 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2019 | 749 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2014 | 27 | 0.030 |
Why?
|
| Genes, Insect | 2 | 2010 | 126 | 0.030 |
Why?
|
| Dwarfism | 1 | 1995 | 104 | 0.030 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 77 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 42 | 0.030 |
Why?
|
| Chimera | 1 | 2014 | 83 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 542 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2013 | 34 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 302 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1993 | 47 | 0.030 |
Why?
|
| Adenosine Deaminase | 1 | 1993 | 89 | 0.030 |
Why?
|
| Skin | 1 | 2016 | 527 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2013 | 12 | 0.030 |
Why?
|
| Transgenes | 1 | 2014 | 336 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 382 | 0.030 |
Why?
|
| Infant | 1 | 2009 | 13049 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 541 | 0.030 |
Why?
|
| Reference Values | 1 | 1994 | 703 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2013 | 152 | 0.030 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2012 | 8 | 0.020 |
Why?
|
| DNA Primers | 2 | 2004 | 636 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 27 | 0.020 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2013 | 52 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 377 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2013 | 40 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 243 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 509 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 95 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 589 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 77 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 206 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2012 | 66 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1995 | 325 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 124 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2013 | 163 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 157 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 701 | 0.020 |
Why?
|
| ras Proteins | 1 | 2013 | 146 | 0.020 |
Why?
|
| Echocardiography | 1 | 2017 | 1126 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2018 | 1580 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 656 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2012 | 149 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 232 | 0.020 |
Why?
|
| Syndrome | 2 | 2009 | 1175 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 343 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 750 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 222 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 162 | 0.020 |
Why?
|
| Rats | 2 | 2009 | 3607 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3414 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2010 | 19 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 2851 | 0.020 |
Why?
|
| Sex Chromosomes | 1 | 2010 | 32 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2010 | 38 | 0.020 |
Why?
|
| Developmental Biology | 1 | 2010 | 15 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 69 | 0.020 |
Why?
|
| Wings, Animal | 1 | 2010 | 35 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2010 | 35 | 0.020 |
Why?
|
| Biophysics | 1 | 2010 | 47 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2010 | 41 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 473 | 0.020 |
Why?
|
| Sex Chromosome Disorders | 1 | 2009 | 9 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 85 | 0.020 |
Why?
|
| Everolimus | 1 | 2010 | 50 | 0.020 |
Why?
|
| Kinetics | 1 | 2011 | 1130 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2010 | 176 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 1087 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 302 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 131 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 79 | 0.020 |
Why?
|
| Estrous Cycle | 1 | 2008 | 36 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 764 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2008 | 54 | 0.020 |
Why?
|
| Synaptonemal Complex | 1 | 1988 | 1 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2010 | 370 | 0.020 |
Why?
|
| Oviducts | 1 | 2008 | 100 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 469 | 0.020 |
Why?
|
| Sirolimus | 1 | 2010 | 241 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2008 | 106 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2009 | 449 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2008 | 193 | 0.020 |
Why?
|
| Ovulation | 1 | 2008 | 107 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 391 | 0.020 |
Why?
|
| Genome, Human | 1 | 2014 | 1331 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 584 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 1995 | 1094 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 495 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2009 | 212 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 806 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 16 | 0.020 |
Why?
|
| Oocytes | 1 | 2008 | 290 | 0.020 |
Why?
|
| Base Composition | 1 | 2006 | 74 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 1986 | 33 | 0.020 |
Why?
|
| Virus Replication | 1 | 2009 | 636 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2006 | 56 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1671 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 2006 | 78 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2006 | 159 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 156 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 236 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 317 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 445 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2010 | 784 | 0.010 |
Why?
|
| Centromere | 1 | 2005 | 72 | 0.010 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 55 | 0.010 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 52 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2006 | 506 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2004 | 124 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 2005 | 201 | 0.010 |
Why?
|
| Automation | 1 | 2004 | 63 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 2005 | 121 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2003 | 35 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1996 | 774 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2005 | 475 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 982 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 136 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 590 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 311 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 403 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 1453 | 0.010 |
Why?
|
| United States | 2 | 2009 | 11669 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 722 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 552 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 1577 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 124 | 0.010 |
Why?
|
| K562 Cells | 1 | 2000 | 97 | 0.010 |
Why?
|
| Risk Factors | 2 | 2005 | 10945 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 2314 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 148 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2000 | 731 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 761 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 9966 | 0.010 |
Why?
|
| Sural Nerve | 1 | 1996 | 46 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1996 | 140 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1996 | 213 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1996 | 85 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1996 | 268 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 7557 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1996 | 134 | 0.010 |
Why?
|
| Cosmids | 1 | 1995 | 42 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 78 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 381 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1993 | 57 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 1993 | 35 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1995 | 285 | 0.010 |
Why?
|
| Plasmids | 1 | 1993 | 459 | 0.010 |
Why?
|
| Pedigree | 1 | 1996 | 1724 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1995 | 794 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 29021 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1988 | 88 | 0.000 |
Why?
|
| Adolescent | 1 | 2005 | 20557 | 0.000 |
Why?
|